Here are the top health news for the day:Show-cause notices to 100 medical collegesAttendance shortfall of faculties is still a matter of concern for the medical colleges as the National Medical Commission (NMC) has issued show-cause notices to 100 medical colleges across the country as the faculties in those institutes failed to meet the 75% attendance criteria.The list of colleges that...
Here are the top health news for the day:
Show-cause notices to 100 medical colleges
Attendance shortfall of faculties is still a matter of concern for the medical colleges as the National Medical Commission (NMC) has issued show-cause notices to 100 medical colleges across the country as the faculties in those institutes failed to meet the 75% attendance criteria.
The list of colleges that received the show-cause notice from the Apex Medical Commission also includes a few colleges in Bengaluru. All these medical colleges have been given 15 days to reply to the notice, failing which they will face punitive action.
For the full story, check out the link given below:
NMC Slaps Show-Cause To 100 Medical Colleges, Here Is The Reason
Drug alert: CDSCO flags 78 drug samples, including Alkem's Pan 40
In its latest drug safety alert, the apex drug regulatory body, Central Drug Standard Control Organisation (CDSCO) has flagged 78 medicine batches for failing to qualify for a random drug sample test for December– 2023.
These include Montelukast Sodium and Levocetirizine Dihydrochloride Tablets manufactured by Bonsai Pharma, Multi-Vitamin Tablets (VITAJACKS-S TABLETS) manufactured by Jackson Laboratories, Telmisartan and Amlodipine Tablets IP (Zensartan-AM Tablets) manufactured by Windlass Biotech Limited, Telmisartan Tablets IP 40 mg (Telmibeck-40 Tablets) manufactured by Biocore Pharmaceuticals, Pregabalin Capsules IP (Pragavir Capsules) manufactured by Mayoford Pharma.
For the full story, check out the link given below:
CDSCO Drug Alert: 78 Drug Samples Including Alkem's Pan 40 Flagged
NMC seeks stakeholder feedback on NExT exam conduct
Amidst the debate and uncertainty regarding the conduct of the National Exit Test (NExT), the National Medical Commission (NMC) has now made the issue open to all the stakeholders.
Through a recent notice, the Apex Medical Commission has asked the stakeholders to submit their feedback on the NMC National Exit Test Regulations, 2023, by 07.02.2024.
For the full story, check out the link given below:
How Will NExT Be Conducted? NMC Invites Feedback From Stakeholders
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd